This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harris, S. L. Articles by Granoff, D. M. Search for Related Content PubMed PubMed Citation Articles by Harris, S. L. Articles by Granoff, D. M.

Age-Related Disparity in Functional Activities of Human Group C Serum Anticapsular Antibodies Elicited by Meningococcal Polysaccharide Vaccine

Children's Hospital Oakland Research Institute, Oakland, California,¹ Department of Pediatrics, Children's Hospital Eastern Ontario, University of Ottawa, Ottawa, Canada²

Received 19 July 2002/ Returned for modification 27 August 2002/ Accepted 23 September 2002

Serum bactericidal activity confers protection against meningococcal disease, but it is not known whether vaccine-induced anticapsular antibodies that lack bactericidal activity are protective. We developed an infant rat challenge model using a naturally occurring O-acetylated strain of Neisseria meningitidis group C and a strain that was negative for O acetylation (OAc). Rats 4 to 7 days of age inoculated intraperitoneally (i.p.) with 10³ CFU of either strain developed >5 x 10⁵ CFU/ml of blood obtained 18 h later. Dilutions of preimmunization sera given i.p. 2 h before the bacterial challenge had no effect on bacteremia, whereas group C anticapsular antibody in sera from adults immunized with meningococcal polysaccharide vaccine conferred complete or partial (>99% decrease in CFU per milliliter of blood) protection against the OAc-positive or OAc-negative strain, respectively, at antibody doses as low as 0.04 µg/rat. Anticapsular antibody at doses fivefold higher (0.18 to 0.2 µg/rat) in pooled sera from children immunized at a mean age of 2.6 years failed to protect rats, but antibody at the same or fivefold-lower dose in a serum pool from a group of children immunized at 4 years of age gave complete or partial protection. Protective activity was observed with some serum pools that lacked detectable complement-mediated bactericidal activity (titers < 1:4) and correlated with increasing antibody avidity. Thus, not only does the magnitude of the group C antibody response to meningococcal polysaccharide vaccine increase with increasing age but there are also age-related affects on antibody functional activity such that higher serum concentrations of vaccine-induced antibody are required for protection of immunized children than for immunized adults.

Editor: D. L. Burns

This article has been cited by other articles:

• Harris, S. L., Tsao, H., Ashton, L., Goldblatt, D., Fernsten, P. (2007). Avidity of the Immunoglobulin G Response to a Neisseria meningitidis Group C Polysaccharide Conjugate Vaccine as Measured by Inhibition and Chaotropic Enzyme-Linked Immunosorbent Assays. CVI 14: 397-403 [Abstract] [Full Text]  
• Welsch, J. A., Granoff, D. (2004). Naturally Acquired Passive Protective Activity against Neisseria meningitidis Group C in the Absence of Serum Bactericidal Activity. Infect. Immun. 72: 5903-5909 [Abstract] [Full Text]  
• Welsch, J. A., Rossi, R., Comanducci, M., Granoff, D. M. (2004). Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a Neisseria meningitidis Candidate Vaccine. J. Immunol. 172: 5606-5615 [Abstract] [Full Text]  
• Harris, S. L., Finn, A., Granoff, D. M. (2003). Disparity in Functional Activity between Serum Anticapsular Antibodies Induced in Adults by Immunization with an Investigational Group A and C Neisseria meningitidis-Diphtheria Toxoid Conjugate Vaccine and by a Polysaccharide Vaccine. Infect. Immun. 71: 3402-3408 [Abstract] [Full Text]  
• Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu-Bobie, J., Arico, B., Brunelli, B., Pieri, A., Santini, L., Savino, S., Serruto, D., Litt, D., Kroll, S., Welsch, J. A., Granoff, D. M., Rappuoli, R., Pizza, M. (2003). Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870. J. Exp. Med. 197: 789-799 [Abstract] [Full Text]